{
    "score": [
        0.7142857142857143
    ],
    "extracted": [
        0
    ],
    "abstract": [
        "amedica & its peers financial comparison ."
    ],
    "id": "216778.train",
    "article": [
        "amedica is one of 19 public companies in the `` medical devices & implants '' industry , but how does it contrast to its peers ? we will compare amedica to similar businesses based on the strength of its valuation , analyst recommendations , earnings , dividends , risk , profitability and institutional ownership . insider & institutional ownership63 .6 % of amedica shares are owned by institutional investors . comparatively , 54.8 % of shares of all `` medical devices & implants '' companies are owned by institutional investors . 0.1 % of amedica shares are owned by company insiders . ",
        "comparatively , 10.3 % of shares of all `` medical devices & implants '' companies are owned by company insiders . strong institutional ownership is an indication that endowments , large money managers and hedge funds believe a stock is poised for long-term growth . valuation and earningsthis table compares amedica and its peers gross revenue , earnings per share and valuation . gross revenuenet incomeprice/earnings ratioamedica $ 15.23 million - $ 16.59 millionn/aamedica competitors $ 1.67 billion $ 207.58 million80 .95 amedica 's peers have higher revenue and earnings than amedica . risk & volatilityamedica has a beta of -2.08 , suggesting that its share price is 308 % less volatile than the s&p 500 . ",
        "comparatively , amedica 's peers have a beta of 0.95 , suggesting that their average share price is 6 % less volatile than the s&p 500 . profitabilitythis table compares amedica and its peers ' net margins , return on equity and return on assets . net marginsreturn on equityreturn on assetsamedica-87.49 % -77.71 % -45.50 % amedica competitors-101.23 % -92.70 % -30.32 % analyst ratingsthis is a summary of recent ratings for amedica and its peers , as reported by marketbeat . com . sell ratingshold ratingsbuy ratingsstrong buy ratingsrating scoreamedica02002 .00 amedica competitors1127341028102 .50 amedica presently has a consensus target price of $ 60.00 , indicating a potential upside of 1,933.90 % . ",
        "as a group , `` medical devices & implants '' companies have a potential upside of 36.52 % . given amedica 's higher possible upside , equities analysts clearly believe amedica is more favorable than its peers . summaryamedica peers beat amedica on 8 of the 12 factors compared . amedica company profileamedica corporation is a commercial biomaterial company . the company is a vertically integrated silicon nitride orthopedic medical device manufacturer . it is focused on using its silicon nitride ceramic technology platform to develop , manufacture and sell a range of medical devices . it is also engaged in developing wear - and corrosion-resistant implant components for hip and knee arthroplasty . ",
        "the company markets its valeo family of silicon nitride interbody spinal fusion devices in the united states , europe and brazil for use in the cervical and thoracolumbar areas of the spine . in addition to its silicon nitride-based spinal fusion products , it markets a line of non-silicon nitride spinal surgery products , which allows the company to provide surgeons and hospitals with a solution for spinal procedures . its valeo interbody spinal fusion devices include anterior lumbar , posterior lumbar , oblique lumbar , transforaminal lumbar , lateral lumbar , cervical and corpectomy .   "
    ]
}